Richard Eisenstadt | Chief Financial Officer |
Jerry McLaughlin | Chief Executive Officer |
Louise Chen | Cantor |
Roy Buchanan | JMP Securities |
Good morning and welcome to the Neos Therapeutics Second Quarter 2020 Financial Results Conference Call. Today's call is being recorded. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow.
For introductory and opening remarks, I am turning the call over to Richard Eisenstadt, CFO of Neos Therapeutics.